COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > SO OATS GUESS WHO IS UP FOR THE NEW BOARD

<< Previous

Bullboard Posts

Next >>

Comment by Hopeforthebeston Jun 29, 2024 1:18pm

87 Views

Post# 36112119

RE:RE:SO OATS GUESS WHO IS UP FOR THE NEW BOARD

Ciao, i would say that investors and the pharma community is aware that gagnon's word is not to be trusted. The inability of the savour, NoShowRonnie, to interest investors or the direction the stock is going is an indication that gagnon's and his actions are already well known. To make ife easy just vote NO to everything these 2 charlatons are pushing.

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3